One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
How To Report the Minor Component of a High-grade Pattern in Radical Prostatectomy Specimens: Time To Abandon the “Tertiary� Terminology?
Systematic Prostate Biopsy Versus Perilesional Sampling: If It Isn’t Broke, Why Fix It?
Correlative Analysis of ATM, RB1, ERCC2, and FANCC Mutations and Pathologic Complete Response After Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Results from the SWOG S1314 Trial
Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma
Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable?
Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review
The Role of Bladder Outlet Obstruction in Male Non-neurogenic Lower Urinary Tract Symptoms—Any Additional News?
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study
Therapy Optimization in the Management of Metastatic Hormone-sensitive Prostate Cancer: Insights from the ARASENS Study
Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update
Challenging the Paradigm of “BCG-unresponsive� Bladder Cancer: Does Additional Bacillus Calmette-Guérin Have an Effect?
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials
[18F]RCCB6 Immuno-Positron Emission Tomography/Computed Tomography for Postoperative Surveillance in Clear Cell Renal Cell Carcinoma: A Pilot Clinical Study
Re: Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study
Re: Incidence and Survival of Secondary Malignancies after External Beam Radiotherapy for Prostate Cancer in the SEER Database
Re: Actinium-225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer (WARMTH Act): A Multicentre, Retrospective Study
Predicting Renal Function following Nephroureterectomy can Impact Timing of Systemic Chemotherapy
Re: CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma
Re: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
Re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108
Re: Katie Gordon, Naomi Warne, Jon Heron, Alexander von Gontard, Carol Joinson. Continence Problems and Mental Health in Adolescents from a UK Cohort. Eur Urol 2023;84:463–70
Re: Michele Gnech, Lisette ’t Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. 2024;85:433–42
Re: Marcin Miszczyk, Pawel Rajawa, Takafumi Yanagisawa, et al. The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol. 2024;85:125–38
Reply to Ping Zhong, Xin Liu, and Limin Liao’s Letter to the Editor re: Michele Gnech, Lisette ’t Hoen, Alexandra Zachou, et al. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children. Eur Urol. 2024;85:433–42
Re: Srikala S. Sridhar, Thomas Powles, Miguel. �. Climent Durán, et al. Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance. Eur Urol 2024:85:154–63
Re: Vipul Patel, Jacques Marescaux, Marcio Covas Moschovas. The Humanitarian Impact of Telesurgery and Remote Surgery in Global Medicine. Eur Urol. 2024;86:88–9
Reply to Chang-Kun Mao, Tao Zhang, and Jun-Ting Li’s Letter to the Editor re: Vipul Patel, Jacques Marescaux, Marcio Covas Moschovas. The Humanitarian Impact of Telesurgery and Remote Surgery in Global Medicine. Eur Urol. 2024;86:88–9
